دورية أكاديمية
أعرض في EDS

Adverse pregnancy outcomes and future risk of heart failure.

التفاصيل البيبلوغرافية
العنوان: Adverse pregnancy outcomes and future risk of heart failure.
المؤلفون: Pabón MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital., Misra A; Division of Cardiovascular Medicine, Brigham and Women's Hospital.; Department of Cardiology, Boston Children's Hospital., Honigberg MC; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
المصدر: Current opinion in cardiology [Curr Opin Cardiol] 2023 May 01; Vol. 38 (3), pp. 215-222. Date of Electronic Publication: 2023 Mar 01.
نوع المنشور: Review; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams and Wilkins Country of Publication: United States NLM ID: 8608087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-7080 (Electronic) Linking ISSN: 02684705 NLM ISO Abbreviation: Curr Opin Cardiol Subsets: MEDLINE
أسماء مطبوعة: Publication: Philadelphia Pa : Lippincott Williams and Wilkins
Original Publication: London ; New York : Gower Academic Journals, c1986-
مواضيع طبية MeSH: Heart Failure*/etiology , Heart Failure*/complications , Cardiovascular Diseases*/etiology, Infant, Newborn ; Pregnancy ; Female ; Humans ; Pregnancy Outcome ; Placenta ; Risk Factors
مستخلص: Purpose of Review: Cardiovascular disease (CVD) is the leading cause of death in women. Women with history of adverse pregnancy outcomes (APOs) have approximately two-fold risk of future CVD, but until recently the association with future heart failure (HF) was unclear. Here, we summarize evidence for associations of APOs with HF, potential underlying mechanisms, and future directions for clinical translation.
Recent Findings: Women with history of hypertensive disorders of pregnancy (HDPs) have roughly two-fold risk of future HF compared with other parous women even after accounting for interval development of coronary artery disease. The HDPs portend heightened risk of HF with both reduced and preserved ejection fraction. Gestational diabetes mellitus (GDM) and other APOs such as preterm delivery, small-for-gestational-age delivery, and placental abruption may also confer additional risk for HF development. Possible underlying mechanisms linking APOs to HF include shared upstream risk factors and genetics, accelerated development of cardiometabolic risk factors postpartum, persistent endothelial and microvascular dysfunction, and impaired natriuretic peptide signaling.
Summary: History of APOs, including HDPs and GDM, confer increased risk for development of HF years after delivery. Further research is needed to define strategies to optimize prepregnancy and postpartum cardiovascular health toward HF prevention.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with preeclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013; 28:1–19.
Riise HK, Sulo G, Tell GS, et al. Incident coronary heart disease after preeclampsia: role of reduced fetal growth, preterm delivery, and parity. J Am Heart Assoc 2017; 6:e004158.
Skjaerven R, Wilcox AJ, Klungsøyr K, et al. Cardiovascular mortality after preeclampsia in one child mothers: prospective, population based cohort study. BMJ 2012; 345:e7677.
Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 2015; 132:1234–1242.
Lee SM, Shivakumar M, Park JW, et al. Long-term cardiovascular outcomes of gestational diabetes mellitus: a prospective UK Biobank study. Cardiovasc Diabetol 2022; 21:221.
Tobias DK, Hu FB, Forman JP, et al. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 2011; 34:1582–1584.
Fadl H, Magnuson A, Östlund I, et al. Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG 2014; 121:1530–1536.
Gunderson EP, Chiang V, Pletcher MJ, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk Development in Young Adults study. J Am Heart Assoc 2014; 3:e000490.
Tobias DK, Stuart JJ, Li S, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med 2017; 177:1735–1742.
Xie W, Wang Y, Xiao S, et al. Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis. BMJ 2022; 378:e070244.
Mao Y, Hu W, Xia B, et al. Association between gestational diabetes mellitus and the risks of type-specific cardiovascular diseases. Front Public Health 2022; 10:940335.
Echouffo-Tcheugui JB, Guan J, Retnakaran R, et al. Gestational diabetes and incident heart failure: a cohort study. Diabetes Care 2021; 44:2346–2352.
Lykke JA, Paidas MJ, Damm P, et al. Preterm delivery and risk of subsequent cardiovascular morbidity and type-II diabetes in the mother. BJOG 2010; 117:274–281.
Tanz LJ, Stuart JJ, Williams PL, et al. Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation 2017; 135:578–589.
Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation 2019; 139:1069–1079.
Ananth CV, Hansen AV, Williams MA, et al. Cardiovascular disease in relation to placental abruption: a population-based cohort study from Denmark. Paediatr Perinat Epidemiol 2017; 31:209–218.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 74:e177–e232.
Honigberg MC, Zekavat SM, Aragam K, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol 2019; 74:2743–2754.
Leon LJ, McCarthy FP, Direk K, et al. Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: A CALIBER study. Circulation 2019; 140:1050–1060.
Wang YX, Arvizu M, Rich-Edwards JW, et al. Hypertensive disorders of pregnancy and subsequent risk of premature mortality. J Am Coll Cardiol 2021; 77:1302–1312.
Malek AM, Wilson DA, Turan TN, et al. Incident heart failure within the first and fifth year after delivery among women with hypertensive disorders of pregnancy and prepregnancy hypertension in a diverse population. J Am Heart Assoc 2021; 10:e021616.
Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018; 72:24–43.
Petersen EE, Davis NL, Goodman D, et al. Vital signs: pregnancy-related deaths, United States, 2011–2015, and strategies for prevention, 13 states, 2013–2017. MMWR Morb Mortal Wkly Rep 2019; 68:423–429.
Garovic VD, White WM, Vaughan L, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol 2020; 75:2323–2334.
Ford NDCS, Ko JY, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization — United States, 2017–2019. MMWR Morb Mortal Wkly Rep 2022; 71:585–591.
Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation 2018; 137:e843–e852.
Rafeeinia A, Tabandeh A, Khajeniazi S, et al. Metabolic syndrome in preeclampsia women in gorgan. Open Biochem J 2014; 8:94–99.
Männistö T, Mendola P, Vääräsmäki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013; 127:681–690.
Haug EB, Horn J, Markovitz AR, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Trøndelag Health Study. JAMA Cardiol 2019; 4:628–635.
Behrens I, Basit S, Lykke JA, et al. Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy. JAMA 2016; 315:1026–1033.
Honigberg MC, Riise HKR, Daltveit AK, et al. Heart failure in women with hypertensive disorders of pregnancy: insights from the cardiovascular disease in Norway project. Hypertension 2020; 76:1506–1513.
Ray JG, Schull MJ, Kingdom JC, et al. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart 2012; 98:1136–1141.
Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2017; 10:e003497.
Williams D, Stout MJ, Rosenbloom JI, et al. Preeclampsia predicts risk of hospitalization for heart failure with preserved ejection fraction. J Am Coll Cardiol 2021; 78:2281–2290.
Hansen AL, Søndergaard MM, Hlatky MA, et al. Adverse pregnancy outcomes and incident heart failure in the women's health initiative. JAMA Netw Open 2021; 4:e2138071.
Bello N, Rendon ISH, Arany Z. The relationship between preeclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62:1715–1723.
Honigberg MC, Givertz MM. Peripartum Cardiomyopathy. BMJ 2019; 364:k5287.
Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia-pathophysiology and clinical presentations: jacc state-of-the-art review. J Am Coll Cardiol 2020; 76:1690–1702.
Castleman JS, Ganapathy R, Taki F, et al. Echocardiographic structure and function in hypertensive disorders of pregnancy: a systematic review. Circ Cardiovasc Imaging 2016; 9:e004888.
Vaught AJ, Kovell LC, Szymanski LM, et al. Acute cardiac effects of severe pre-eclampsia. J Am Coll Cardiol 2018; 72:1–11.
O’Driscoll JM, Giorgione V, Edwards JJ, et al. Myocardial mechanics in hypertensive disorders of pregnancy: a systematic review and meta-analysis. Hypertension 2022; 79:391–398.
Melchiorre K, Sutherland GR, Liberati M, et al. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011; 58:709–715.
Countouris ME, Villanueva FS, Berlacher KL, et al. Association of hypertensive disorders of pregnancy with left ventricular remodeling later in life. J Am Coll Cardiol 2021; 77:1057–1068.
Boardman H, Lamata P, Lazdam M, et al. Variations in cardiovascular structure, function, and geometry in midlife associated with a history of hypertensive pregnancy. Hypertension 2020; 75:1542–1550.
Borghi C, Esposti DD, Immordino V, et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol 2000; 183:140–147.
Scantlebury DC, Kane GC, Wiste HJ, et al. Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart 2015; 101:1584–1590.
Reddy M, Wright L, Rolnik DL, et al. Evaluation of cardiac function in women with a history of preeclampsia: a systematic review and meta-analysis. J Am Heart Assoc 2019; 8:e013545.
Levine LD, Ky B, Chirinos JA, et al. Prospective evaluation of cardiovascular risk 10 years after a hypertensive disorder of pregnancy. J Am Coll Cardiol 2022; 79:2401–2411.
Wu P, Kwok CS, Haththotuwa R, et al. Preeclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis. Diabetologia 2016; 59:2518–2526.
Bytautiene E, Bulayeva N, Bhat G, et al. Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol 2013; 208:388e1-.e10.
Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89:6239–6243.
Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8:831–840.
Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012; 485:333–338.
Pàez O, Alfie J, Gorosito M, et al. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of preeclampsia. Clin Exp Hypertens 2009; 31:544–552.
Germain AM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49:90–95.
Lampinen KH, Rönnback M, Kaaja RJ, et al. Impaired vascular dilatation in women with a history of preeclampsia. J Hypertens 2006; 24:751–756.
Elvan-Taşpinar A, Bots ML, Franx A, et al. Stiffness of the arterial wall, joints and skin in women with a history of preeclampsia. J Hypertens 2005; 23:147–151.
Zoet GA, Benschop L, Boersma E, et al. Prevalence of subclinical coronary artery disease assessed by coronary computed tomography angiography in 45- to 55-year-old women with a history of preeclampsia. Circulation 2018; 137:877–879.
Weissgerber TL, Milic NM, Milin-Lazovic JS, et al. Impaired flow-mediated dilation before, during, and after preeclampsia: a systematic review and meta-analysis. Hypertension 2016; 67:415–423.
Honigberg MC, Zekavat SM, Raghu VK, et al. Microvascular outcomes in women with a history of hypertension in pregnancy. Circulation 2022; 145:552–554.
Catov JM, Muldoon MF, Gandley RE, et al. Maternal vascular lesions in the placenta predict vascular impairments a decade after delivery. Hypertension 2022; 79:424–434.
Houben AJ, de Leeuw PW, Peeters LL. Configuration of the microcirculation in preeclampsia: possible role of the venular system. J Hypertens 2007; 25:1665–1670.
Mikkelsen AL, Schütten G, Asping U, et al. Plasma concentration of atrial natriuretic peptide in normal pregnant women and in pregnant women with preeclampsia. Gynecol Obstet Invest 1991; 31:192–195.
Otsuki Y, Okamoto E, Iwata I, et al. Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia. J Endocrinol 1987; 114:325–328.
Fievet P, Fournier A, de Bold A, et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertens 1988; 1:16–21.
Tihtonen KM, Kööbi T, Vuolteenaho O, et al. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol 2007; 196:328e1–7.
Hauspurg A, Marsh DJ, McNeil RB, et al. Association of N-terminal Pro-brain natriuretic peptide concentration in early pregnancy with development of hypertensive disorders of pregnancy and future hypertension. JAMA Cardiol 2022; 7:268–276.
Honigberg MC, Truong B, Khan RR, et al. Genome-wide meta-analysis identifies novel maternal risk variants and enables polygenic prediction of preeclampsia and gestational hypertension. medRxiv 2022; 2022.11.30.22282929.
Sun BB, Maranville JC, Peters JE, et al. Genomic atlas of the human plasma proteome. Nature 2018; 558:73–79.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief 2020; (360):1–8.
Fisher SC, Kim SY, Sharma AJ, et al. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003–2009. Prev Med 2013; 56:372–378.
Tanaka M, Jaamaa G, Kaiser M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health 2007; 97:163–170.
Grobman WA, Parker CB, Willinger M, et al. Racial disparities in adverse pregnancy outcomes and psychosocial stress. Obstet Gynecol 2018; 131:328–335.
Teal EN, Appiagyei A, Sheffield-Abdullah K, et al. Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy. Pregnancy Hypertens 2022; 28:88–93.
Hauspurg A, Lemon L, Cabrera C, et al. Racial differences in postpartum blood pressure trajectories among women after a hypertensive disorder of pregnancy. JAMA Netw Open 2020; 3:e2030815.
Christensen MH, Rubin KH, Petersen TG, et al. Cardiovascular and metabolic morbidity in women with previous gestational diabetes mellitus: a nationwide register-based cohort study. Cardiovasc Diabetol 2022; 21:179.
Company Calabuig AM, Nunez E, Sánchez A, et al. Three-dimensional echocardiography and cardiac strain imaging in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2021; 58:278–284.
Appiah D, Schreiner PJ, Gunderson EP, et al. Association of gestational diabetes mellitus with left ventricular structure and function: the CARDIA Study. Diabetes Care 2016; 39:400–407.
Retnakaran R, Shah BR. Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease. BMC Med 2022; 20:389.
Seferović PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J 2015; 36:1718–1727. 27a-27c.
Brewster S, Floras J, Zinman B, et al. Endothelial function in women with and without a history of glucose intolerance in pregnancy. J Diabetes Res 2013; 2013:382670.
Anastasiou E, Lekakis JP, Alevizaki M, et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998; 21:2111–2115.
Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990–2019. JAMA Pediatr 2022; 176:787–796.
Chen SN, Cheng CC, Tsui KH, et al. Hypertensive disorders of pregnancy and future heart failure risk: a nationwide population-based retrospective cohort study. Pregnancy Hypertens 2018; 13:110–115.
Crump C, Groves A, Sundquist J, et al. Association of preterm birth with long-term risk of heart failure into adulthood. JAMA Pediatr 2021; 175:689–697.
DesJardin JT, Healy MJ, Nah G, et al. Placental abruption as a risk factor for heart failure. Am J Cardiol 2020; 131:17–22.
Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation 2021; 143:e902–e916.
Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015; 100:1646–1653.
Ormesher L, Higson S, Luckie M, et al. Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP): a randomized double-blind placebo-controlled feasibility trial. Hypertension 2020; 76:1828–1837.
Tschiderer L, Seekircher L, Kunutsor SK, et al. Breastfeeding is associated with a reduced maternal cardiovascular risk: systematic review and meta-analysis involving data from 8 studies and 1 192 700 parous women. J Am Heart Assoc 2022; 11:e022746.
معلومات مُعتمدة: K08 HL166687 United States HL NHLBI NIH HHS
تواريخ الأحداث: Date Created: 20230317 Date Completed: 20230406 Latest Revision: 20230511
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10079602
DOI: 10.1097/HCO.0000000000001035
PMID: 36927985
قاعدة البيانات: MEDLINE
الوصف
تدمد:1531-7080
DOI:10.1097/HCO.0000000000001035